Atlas Trials

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

Clinical trial NCT01159405 · UNKNOWN

Trial details

NCT number
NCT01159405
Sponsor
SeeCure LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-06-01
Primary completion
2015-03-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.